← 產業報告目錄

Vascular Access Device Market by Type [Central, Peripheral Venous (PIVC, Midline, Arterial), Intraosseous], Route of Insertion, Application [Drug, Fluid Administration, Diagnostic & Testing], End User [Hospital (Public, Private)] - Global Forecast to 2031

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2026-02-11頁數 445報告編號 MD5434

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The vascular access device market is projected to reach USD 8.68 billion by 2031 from USD 6.27 billion in 2026, at a CAGR of 6.7% from 2026 to 2031. The vascular access device market is expanding due to the rise in chronic diseases such as cancer, heart disorders, and kidney failure, all of which require intravenous therapies. The increase in hospitalizations, surgical procedures, and the demand for critical care and emergency services is driving the need for these devices. Additionally, advancements in technology—such as safety-engineered devices, antimicrobial coatings, and ultrasound-guided placement—are enhancing clinical outcomes, reducing complications, and supporting broader adoption of vascular access devices. Besides, the growing elderly population, rising ambulatory care and home healthcare facilities, and the tremendous emphasis on infection control and patient safety are all driving the demand for vascular access devices in the healthcare system. “Based on type, the peripheral vascular access device segment is expected to experience the highest CAGR during the forecast period.” By type, the peripheral vascular access device segment is estimated to lead the vascular access device market because of the increasing need for short-term intravenous therapy in hospitals and other medical facilities. The demand for peripheral vascular access devices has been further propelled by the rise in chronic diseases, surgical and emergency procedures, and increased use of IV medications and fluids. Apart from these benefits, the devices are also preferred for their insertion convenience, cost, and lower risk of severe complications than central access. Moreover, new catheter materials, engineered safety designs that avoid needlestick injury, and a movement toward outpatient and more affordable care models are also contributing to the market's growth. “Based on application, the drug administration segment is projected to register the highest CAGR during the forecast period.” By application, the drug administration segment is projected to grow at the highest rate due to the increasing use of intravenous therapies in the treatment of chronic illnesses like cancer, heart diseases, infections, and autoimmune disorders. Demand is additionally supported by increasing dependence on IV drug delivery for chemotherapy, antibiotics, biologics, and pain management, owing to its rapid onset and higher bioavailability. Besides, the increase in hospital admissions, the extension of outpatient infusion centers, and home-based IV therapy are all contributing to the segment’s growth. The innovative features of vascular access devices, such as better dosing accuracy, lower infection risks, and long-term drug delivery support, are all contributing to their adoption in healthcare settings. “Based on end user, the clinic & ambulatory care centers segment is expected to grow at the highest rate during the forecast period.” The rise of clinics and ambulatory care centers has been a major factor in the growth of the vascular access device market, mainly driven by the trend of hospitals moving patients to outpatient care, which, in turn, is expected to cut down on overall healthcare costs. Besides, the scale-up of minimally invasive procedures, infusion therapies, chronic disease management, and same-day surgeries has contributed to the need for efficient and safe vascular access in these environments. Access to easy-to-use, low-complication vascular access devices is a major factor behind the rapid adoption by clinics and ASCs. Also, favorable reimbursement systems, patient preference for shorter recovery times, and the growth of stand-alone specialty clinics are some of the reasons further contributing to the market expansion. “Asia Pacific is estimated to register the highest CAGR during the forecast period.” The growth of outpatient services and facilities has significantly boosted the vascular access device market. Hospitals and patients are increasingly shifting their preference from inpatient to outpatient services due to the cost savings and reduced inconvenience associated with outpatient care. The rising use of vascular access devices for small surgeries, infusion therapies, chemotherapy administration, and chronic disease management has also contributed to market growth. Additionally, advancements in technology have enabled the quick, sterile, and straightforward insertion of these devices, further enhancing their appeal. Other favorable factors for the use of vascular access devices in clinics and ambulatory care centers include supportive reimbursement policies, quick procedure turnaround times, and patients' growing preference for same-day treatments. Key players in the vascular access device market Some of the major players in this market are Becton, Dickinson and Company (US), Teleflex Incorporated (US), ICU Medical, Inc. (US), B. Braun SE (Germany), AngioDynamics, Inc. (US), Medtronic, Plc (Ireland), Merit Medical Systems Inc. (US), Terumo Corporation (Japan), Nipro (Japan), Vygon (France), AMECATH (Egypt), Medical Components, Inc. (US), HealthLine Medical Products (US), Cook Medical (US), and Access Vascular, Inc. (US). Research Coverage: The report analyzes the vascular access device market and aims to estimate its size and future growth potential based on various segments, such as angioplasty stents, endovascular aneurysm repair stent grafts, inferior cava filters, catheters, angioplasty balloons, plaque modification devices, hemodynamic flow alteration devices, other devices, and end users. The report includes a product portfolio matrix of various vascular access devices available in the market. It also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies. Reasons to Buy the Report The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall vascular access device market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities. This report provides insights into the following pointers: • Analysis of key divers (Growing prevalence of lifestyle diseases, increasing number of chemotherapy procedures, growing use of vascular access devices in pediatric patients), restraints (High cost associated with placement and maintenance of vascular access device, product recalls and failures), challenges (Shortage of skilled professionals, risks associated with vascular access devices), and opportunities (Technological Advancements, growth in number of hospitals) • Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the vascular access device market. • Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new product launches in the vascular access device market • Market Development: Comprehensive information on the lucrative emerging markets by angioplasty stents, structural heart devices, catheters, angioplasty balloons, plaque modification devices, hemodynamic flow alteration devices, other devices, and end users. • Market Diversification: Exhaustive information about new products and services or product and service enhancements, growing geographies, recent developments, and investments in the vascular access device market. • Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products and services, and capacities of the major competitors in the vascular access device market.
目錄 Table of Contents
1 INTRODUCTION 38 1.1 STUDY OBJECTIVES 38 1.2 MARKET DEFINITION 38 1.3 STUDY SCOPE 39 1.3.1 MARKETS COVERED & REGIONAL SEGMENTATION 39 1.3.2 INCLUSIONS & EXCLUSIONS 40 1.3.3 YEARS CONSIDERED 41 1.3.4 CURRENCY CONSIDERED 41 1.4 STAKEHOLDERS 42 1.5 SUMMARY OF CHANGES 42 2 EXECUTIVE SUMMARY 43 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 43 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 44 2.3 DISRUPTIVE TRENDS IN VASCULAR ACCESS DEVICE MARKET 45 2.4 HIGH GROWTH SEGMENTS 46 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 47 3 PREMIUM INSIGHTS 48 3.1 VASCULAR ACCESS DEVICE MARKET OVERVIEW 48 3.2 ASIA PACIFIC: VASCULAR ACCESS DEVICE MARKET, BY COUNTRY AND END USER 49 3.3 GEOGRAPHIC SNAPSHOT OF VASCULAR ACCESS DEVICE MARKET 50 4 MARKET OVERVIEW 51 4.1 INTRODUCTION 51 4.2 MARKET DYNAMICS 51 4.2.1 DRIVERS 52 4.2.1.1 Rising global prevalence of chronic and lifestyle-related diseases 52 4.2.1.2 Rapid growth in the geriatric population and associated vascular disease burden 53 4.2.1.3 Favorable reimbursement scenario for vascular procedures 54 4.2.1.4 Increase in cancer incidence driving demand for vascular access devices in chemotherapy 55 4.2.2 RESTRAINTS 56 4.2.2.1 High costs of vascular access device placement and maintenance 56 4.2.2.2 Rising product failures and device recalls 56 4.2.3 OPPORTUNITIES 57 4.2.3.1 Technological innovation in vascular access devices 57 4.2.3.2 Growing adoption of midline catheters in clinical and outpatient settings 58 4.2.4 CHALLENGES 58 4.2.4.1 Clinical complications associated with vascular access devices 58 4.2.4.2 Shortage of skilled professionals for vascular access device placement and management 59 4.3 UNMET NEEDS AND WHITE SPACES 59 4.3.1 UNMET NEEDS IN VASCULAR ACCESS DEVICE MARKET 59 4.3.2 WHITE SPACE OPPORTUNITIES 60 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 62 4.4.1 INTERCONNECTED MARKETS 62 4.4.2 CROSS-SECTOR OPPORTUNITIES 63 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 64 5 INDUSTRY TRENDS 65 5.1 PORTER’S FIVE FORCES ANALYSIS 65 5.1.1 THREAT OF NEW ENTRANTS 66 5.1.2 THREAT OF SUBSTITUTES 67 5.1.3 BARGAINING POWER OF BUYERS 67 5.1.4 BARGAINING POWER OF SUPPLIERS 67 5.1.5 INTENSITY OF COMPETITIVE RIVALRY 67 5.2 MACROECONOMIC OUTLOOK 68 5.2.1 INTRODUCTION 68 5.2.2 GDP TRENDS & FORECAST 68 5.2.3 TRENDS IN GLOBAL MEDICAL DEVICES INDUSTRY 69 5.2.4 TRENDS IN GLOBAL HEALTHCARE INDUSTRY 70 5.3 SUPPLY CHAIN ANALYSIS 70 5.4 VALUE CHAIN ANALYSIS 72 5.5 ECOSYSTEM ANALYSIS 74 5.6 PRICING ANALYSIS 75 5.6.1 AVERAGE SELLING PRICE TREND OF CENTRAL VENOUS ACCESS DEVICES, BY TYPE (2023–2025) 75 5.6.2 AVERAGE SELLING PRICE TREND OF PERIPHERAL VASCULAR ACCESS DEVICES, BY TYPE (2023–2025) 76 5.6.3 AVERAGE SELLING PRICE TREND OF KEY PRODUCTS, BY APPLICATION (2023–2025) 77 5.6.4 AVERAGE SELLING PRICE TREND, BY REGION (2023–2025) 77 5.7 TRADE ANALYSIS 78 5.7.1 IMPORT DATA FOR HS CODE 9018.39 79 5.7.2 EXPORT DATA FOR HS CODE 9018.39 79 5.8 KEY CONFERENCES & EVENTS, 2026–2027 80 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 81 5.10 INVESTMENT & FUNDING SCENARIO 82 5.11 CASE STUDY ANALYSIS 83   5.12 IMPACT OF US TARIFFS–VASCULAR ACCESS DEVICE MARKET 85 5.12.1 INTRODUCTION 85 5.12.2 KEY TARIFF RATES 85 5.12.3 PRICE IMPACT ANALYSIS 86 5.12.4 IMPACT ON COUNTRIES/REGIONS 87 5.12.5 IMPACT ON END-USE INDUSTRIES 89 5.12.5.1 Hospitals 89 5.12.5.2 Clinics 89 5.12.5.3 Ambulatory care centers 89 5.12.5.4 Other end users 90 6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 91 6.1 KEY EMERGING TECHNOLOGIES 91 6.1.1 NEEDLE-FREE AND CLOSED IV SYSTEMS 91 6.1.2 ULTRASOUND-GUIDED AND TIP-NAVIGATION SYSTEMS 91 6.2 COMPLEMENTARY TECHNOLOGIES 92 6.2.1 VEIN VISUALIZATION SYSTEMS 92 6.2.2 INFUSION PUMPS AND FLOW CONTROL SYSTEMS 92 6.3 ADJACENT TECHNOLOGIES 92 6.3.1 ULTRASOUND SYSTEMS FOR VASCULAR ACCESS 92 6.4 TECHNOLOGY/PRODUCT ROADMAP 93 6.4.1 NEAR TERM (2025–2027) 93 6.4.2 MID TERM (2028–2030) 94 6.4.3 LONG TERM (2030+) 94 6.5 PATENT ANALYSIS 96 6.5.1 JURISDICTION & TOP APPLICANT ANALYSIS 97 6.6 FUTURE APPLICATIONS 99 6.6.1 HOME-BASED AND REMOTE INFUSION THERAPIES 99 6.6.2 SMART VASCULAR ACCESS DEVICES WITH SENSOR INTEGRATION 99 6.6.3 EXPANSION OF CRITICAL CARE AND EXTRACORPOREAL THERAPIES 100 6.6.4 ULTRASOUND-GUIDED AND ROBOTIC VASCULAR ACCESS PLACEMENT 100 6.6.5 ADVANCED ANTIMICROBIAL AND BIOCOMPATIBLE CATHETER TECHNOLOGIES 100 6.6.6 PRECISION MEDICINE AND SPECIALIZED DRUG DELIVERY APPLICATIONS 100 6.7 IMPACT OF AI/GENERATIVE AI ON VASCULAR ACCESS DEVICE MARKET 101 6.7.1 BEST PRACTICES IN VASCULAR ACCESS DEVICE MARKET 102 6.7.2 CASE STUDIES OF AI IMPLEMENTATION IN VASCULAR ACCESS DEVICE MARKET 103 6.7.3 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS 104 6.7.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN VASCULAR ACCESS DEVICE MARKET 105 7 REGULATORY LANDSCAPE & SUSTAINABILITY INITIATIVES 106 7.1 REGIONAL REGULATIONS & COMPLIANCE 106 7.1.1 REGULATORY ANALYSIS 106 7.1.1.1 North America 106 7.1.1.1.1 US 106 7.1.1.1.2 Canada 106 7.1.1.2 Europe 107 7.1.1.3 Asia Pacific 107 7.1.1.4 Latin America 108 7.1.1.5 Middle East & Africa 108 7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 109 7.2 INDUSTRY STANDARDS 111 7.2.1 QUALITY MANAGEMENT SYSTEM FOR MEDICAL DEVICES (ISO 13485) 111 7.2.2 BIOLOGICAL EVALUATION OF MEDICAL DEVICES (ISO 10993) 111 7.2.3 INTRAVASCULAR CATHETERS (ISO 10555) 111 7.2.4 RISK MANAGEMENT FOR MEDICAL DEVICES (ISO 14971) 112 7.3 SUSTAINABILITY INITIATIVES 112 7.3.1 ENVIRONMENTAL SUSTAINABILITY IN VASCULAR ACCESS PRODUCT LIFECYCLE- BECTON, DICKINSON AND COMPANY 112 7.3.2 RESOURCE EFFICIENCY AND WASTE REDUCTION IN MEDICAL DEVICE MANUFACTURING – VYGON 112 7.3.3 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES 113 7.3.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 114 8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 116 8.1 DECISION-MAKING PROCESS 116 8.2 KEY BUYER STAKEHOLDERS AND THEIR EVALUATION CRITERIA 118 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 118 8.2.2 BUYING CRITERIA 119 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 121 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 122 8.5 MARKET PROFITABILITY 122 9 VASCULAR ACCESS DEVICE MARKET, BY TYPE 124 9.1 INTRODUCTION 125 9.2 CENTRAL VENOUS ACCESS DEVICES 125 9.2.1 PERIPHERALLY INSERTED CENTRAL CATHETERS 127 9.2.1.1 Enhanced convenience and risk reduction boost PICC adoption 127 9.2.2 TUNNELED CATHETERS 128 9.2.2.1 Advantages of tunneled catheters, such as lower risk of infection and lower chances of accidental removal, to boost demand 128 9.2.2.2 Volume analysis for tunneled cathers market, by region, 2024–2031 (Units) 130 9.2.3 NON-TUNNELED CATHETERS 130 9.2.3.1 Increasing adoption of non-tunneled CVCs driven by affordability and their critical role in emergency care 130 9.2.3.2 Volume analysis for non-tunneled cathers market, by region, 2024–2031 (Units) 132 9.2.4 IMPLANTABLE PORTS 132 9.2.4.1 Implantable conventional ports 134 9.2.4.1.1 Lowest risk of infection associated with implanted ports to support growth 134 9.2.4.2 Implantable power injectable ports 135 9.2.4.2.1 Increasing chemotherapy treatments and high-flow infusion needs fuel demand for implantable power injectable ports 135 9.3 PERIPHERAL VASCULAR ACCESS DEVICES 136 9.3.1 PERIPHERAL VENOUS ACCESS DEVICES 138 9.3.1.1 Peripheral intravenous catheters 140 9.3.1.1.1 Growing hospitalizations and widespread IV therapy drive demand for peripheral intravenous catheters in healthcare 140 9.3.1.2 Volume analysis for peripheral intravenous catheters market, by region, 2024–2031 (Units) 141 9.3.1.3 Midline catheters 141 9.3.1.3.1 Cost-efficiency and extended treatment capabilities drive midline catheter growth in vascular access markets 141 9.3.1.3.2 MST max barrier midline catheters 143 9.3.1.3.3 Integrated/Accelerated midline catheters 144 9.3.1.4 Butterfly/Winged steel needles 146 9.3.1.4.1 Wide usage of winged steel needles in blood sampling and diagnosis to propel growth 146 9.3.2 PERIPHERAL ARTERIAL ACCESS DEVICES 148 9.3.2.1 Real-time hemodynamic monitoring in critical and surgical care to drive market 148 9.3.2.2 Volume analysis for peripheral arterial access devices market, by region, 2024–2031 (Units) 150 9.4 ACCESSORIES 150 9.4.1 RECURRENT NEED FOR ACCESSORIES TO BOOST MARKET 150 9.5 INTRAOSSEOUS VASCULAR ACCESS DEVICES 152 9.5.1 INCREASING INCIDENCE OF CARDIAC ARRESTS TO DRIVE DEMAND FOR INTRAOSSEOUS VASCULAR ACCESS DEVICES 152 10 VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION 154 10.1 INTRODUCTION 155 10.2 INTRAVENOUS 155 10.2.1 GROWING HOSPITALIZATIONS AND DEMAND FOR FAST THERAPEUTIC EFFECTS DRIVE USAGE OF INTRAVENOUS ROUTE 155   10.3 SUBCUTANEOUS 157 10.3.1 RISING CANCER CASES AND DEMAND FOR LONG-TERM THERAPIES DRIVE SEGMENTAL GROWTH 157 10.4 INTRAOSSEOUS 158 10.4.1 RISING PREVALENCE OF CORONARY ARTERY DISEASES TO DRIVE MARKET GROWTH 158 11 VASCULAR ACCESS DEVICE MARKET, BY APPLICATION 160 11.1 INTRODUCTION 161 11.2 DRUG ADMINISTRATION 161 11.2.1 CHEMOTHERAPY 163 11.2.1.1 Rising cancer cases to propel chemotherapy demand and boost market growth 163 11.2.2 OTHER DRUG ADMINISTRATION APPLICATIONS 164 11.3 FLUID & NUTRITION ADMINISTRATION 165 11.3.1 GROWING USE OF PERIPHERAL VASCULAR ACCESS DEVICES FOR SHORT-TERM NUTRITIONAL THERAPY TO SUPPORT MARKET 165 11.4 BLOOD TRANSFUSION 167 11.4.1 FREQUENT NEED FOR BLOOD TRANSFUSION IN THE TREATMENT OF VARIOUS CONDITIONS TO BOOST GROWTH 167 11.5 DIAGNOSTICS & TESTING 168 11.5.1 GROWING POPULARITY OF PERIPHERAL LINES FOR DIAGNOSTIC & TESTING APPLICATIONS TO DRIVE MARKET GROWTH 168 12 VASCULAR ACCESS DEVICE MARKET, BY END USER 170 12.1 INTRODUCTION 171 12.2 HOSPITALS 171 12.2.1 PUBLIC HOSPITALS 173 12.2.1.1 Affordability and accessibility drive patients toward public hospitals 173 12.2.2 PRIVATE HOSPITALS 174 12.2.2.1 Rising availability of specialized treatments and diagnostic services in private hospitals fuels growth 174 12.3 CLINICS 175 12.3.1 INCREASING DEMAND FOR OUTPATIENT PROCEDURES AND COST-EFFECTIVE TREATMENTS TO PROPEL MARKET 175 12.4 AMBULATORY CARE CENTERS 177 12.4.1 INCREASING DEMAND FOR OUTPATIENT PROCEDURES AND COST-EFFECTIVE TREATMENTS TO SUPPORT MARKET GROWTH 177 12.5 OTHER END USERS 178   13 VASCULAR ACCESS DEVICE MARKET, BY REGION 180 13.1 INTRODUCTION 181 13.2 NORTH AMERICA 181 13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 181 13.2.2 NORTH AMERICA VOLUME ANALYSIS FOR CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE (UNITS) 184 13.2.3 NORTH AMERICA VOLUME ANALYSIS FOR PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE (UNITS) 185 13.2.4 US 188 13.2.4.1 US to dominate North American vascular access device market during forecast period 188 13.2.5 CANADA 192 13.2.5.1 Rising cancer prevalence and advanced research initiatives propel Canada's vascular access device market growth. 192 13.3 EUROPE 197 13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 197 13.3.2 EUROPE VOLUME ANALYSIS FOR CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE (UNITS) 199 13.3.3 EUROPE VOLUME ANALYSIS FOR PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE (UNITS) 200 13.3.4 GERMANY 203 13.3.4.1 Germany to dominate European vascular access device market during forecast period 203 13.3.5 UK 207 13.3.5.1 Increased need for intravenous treatments due to CKD and CHD drives market growth 207 13.3.6 FRANCE 212 13.3.6.1 Growing elderly population and healthcare needs foster rapid market growth for vascular access devices in France 212 13.3.7 ITALY 216 13.3.7.1 Strong healthcare policies by government to propel growth 216 13.3.8 SPAIN 221 13.3.8.1 Growing geriatric population to increase demand for vascular access devices 221 13.3.9 REST OF EUROPE 225 13.4 ASIA PACIFIC 229 13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 229 13.4.2 ASIA PACIFIC: VOLUME ANALYSIS FOR CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE (UNITS) 232 13.4.3 ASIA PACIFIC: VOLUME ANALYSIS FOR PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE (UNITS) 233 13.4.4 CHINA 236 13.4.4.1 China to dominate Asia Pacific’s vascular access device market during forecast period. 236   13.4.5 INDIA 241 13.4.5.1 Increasing healthcare expenditure and chronic disease prevalence support market growth in India 241 13.4.6 JAPAN 245 13.4.6.1 Growing healthcare needs among elderly individuals fuel vascular access device market expansion in Japan. 245 13.4.7 AUSTRALIA 250 13.4.7.1 Rising demand for pharmaceuticals and increasing advancements in drug formulations to drive market 250 13.4.8 SOUTH KOREA 254 13.4.8.1 Increasing diabetes and CKD prevalence to drive the market growth 254 13.4.9 REST OF ASIA PACIFIC 259 13.5 LATIN AMERICA 263 13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 263 13.5.2 LATIN AMERICA: VOLUME ANALYSIS FOR CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE (UNITS) 265 13.5.3 LATIN AMERICA: VOLUME ANALYSIS FOR PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE (UNITS) 266 13.5.4 BRAZIL 269 13.5.4.1 Expanding chronic disease prevalence in Brazil supports demand growth 269 13.5.5 MEXICO 274 13.5.5.1 Growing ESRD cases and obesity trends to propel market growth 274 13.5.6 REST OF LATIN AMERICA 278 13.6 MIDDLE EAST & AFRICA 283 13.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 283 13.6.2 MIDDLE EAST & AFRICA: VOLUME ANALYSIS FOR CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE (UNITS) 285 13.6.3 MIDDLE EAST & AFRICA: VOLUME ANALYSIS FOR CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE (UNITS) 286 13.6.4 GCC COUNTRIES 289 13.6.4.1 Kingdom of Saudi Arabia 293 13.6.4.1.1 Rising chronic disease burden and strategic healthcare investments to drive market 293 13.6.4.2 United Arab Emirates 298 13.6.4.2.1 Healthcare infrastructural development and rising medical tourism to drive demand 298 13.6.4.3 Rest of GCC Countries 302 13.6.5 REST OF MIDDLE EAST & AFRICA 306   14 COMPETITIVE LANDSCAPE 311 14.1 INTRODUCTION 311 14.2 KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2024–2026 311 14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VASCULAR ACCESS DEVICE MARKET 312 14.3 REVENUE ANALYSIS, 2023–2025 314 14.4 MARKET SHARE ANALYSIS, 2025 315 14.4.1 GLOBAL MARKET SHARE ANALYSIS (2025) 315 14.4.2 US MARKET SHARE ANALYSIS (2025) 317 14.4.3 EUROPE MARKET SHARE ANALYSIS (2025) 318 14.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 319 14.5.1 STARS 319 14.5.2 EMERGING LEADERS 319 14.5.3 PERVASIVE PLAYERS 319 14.5.4 PARTICIPANTS 319 14.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 321 14.5.5.1 Company footprint 321 14.5.5.2 Type footprint 322 14.5.5.3 Route of insertion footprint 322 14.5.5.4 Application footprint 323 14.5.5.5 Region footprint 324 14.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 325 14.6.1 PROGRESSIVE COMPANIES 325 14.6.2 RESPONSIVE COMPANIES 325 14.6.3 DYNAMIC COMPANIES 325 14.6.4 STARTING BLOCKS 325 14.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 327 14.6.5.1 Detailed list of key startups/SMEs 327 14.6.5.2 Competitive benchmarking of key startups/SMEs 328 14.7 COMPANY VALUATION AND FINANCIAL METRICS 329 14.7.1 FINANCIAL METRICS 329 14.7.2 COMPANY VALUATION 329 14.8 BRAND/PRODUCT COMPARISON 330 14.9 COMPETITIVE SCENARIO 331 14.9.1 PRODUCT LAUNCHES & APPROVALS 331 14.9.2 DEALS 332 14.9.3 EXPANSIONS 333 14.9.4 OTHER DEVELOPMENTS 335   15 COMPANY PROFILES 336 15.1 KEY PLAYERS 336 15.1.1 BECTON, DICKINSON AND COMPANY 336 15.1.1.1 Business overview 336 15.1.1.2 Products offered 337 15.1.1.3 Recent developments 343 15.1.1.3.1 Product launches & approvals 343 15.1.1.3.2 Other developments 343 15.1.1.4 MnM view 344 15.1.1.4.1 Right to win 344 15.1.1.4.2 Strategic choices 344 15.1.1.4.3 Weaknesses & competitive threats 344 15.1.2 TERUMO CORPORATION 345 15.1.2.1 Business overview 345 15.1.2.2 Products offered 346 15.1.2.3 Recent developments 347 15.1.2.3.1 Product launches & approvals 347 15.1.2.3.2 Expansions 348 15.1.2.3.3 Other developments 348 15.1.3 TELEFLEX INCORPORATED 349 15.1.3.1 Business overview 349 15.1.3.2 Products offered 350 15.1.3.3 Recent developments 352 15.1.3.3.1 Product launches & approvals 352 15.1.3.3.2 Deals 353 15.1.3.3.3 Other developments 353 15.1.3.4 MnM view 354 15.1.3.4.1 Right to win 354 15.1.3.4.2 Strategic choices 354 15.1.3.4.3 Weaknesses & competitive threats 354 15.1.4 ICU MEDICAL INC. 355 15.1.4.1 Business overview 355 15.1.4.2 Products offered 356 15.1.4.3 Recent developments 359 15.1.4.3.1 Product launches & approvals 359 15.1.4.3.2 Expansions 360 15.1.4.3.3 Other developments 360 15.1.4.4 MnM view 360 15.1.4.4.1 Right to win 360 15.1.4.4.2 Strategic choices 361 15.1.4.4.3 Weaknesses & competitive threats 361   15.1.5 B. BRAUN SE 362 15.1.5.1 Business overview 362 15.1.5.2 Products offered 363 15.1.5.3 Recent developments 368 15.1.5.3.1 Product launches & approvals 368 15.1.5.3.2 Other developments 369 15.1.5.4 MnM view 369 15.1.5.4.1 Right to win 369 15.1.5.4.2 Strategic choices 369 15.1.5.4.3 Weaknesses and competitive threats 369 15.1.6 MERIT MEDICAL SYSTEMS 370 15.1.6.1 Business overview 370 15.1.6.2 Products offered 371 15.1.6.3 Recent developments 373 15.1.6.3.1 Product launches 373 15.1.6.3.2 Deals 374 15.1.6.3.3 Other developments 374 15.1.7 NIPRO CORPORATION 375 15.1.7.1 Business overview 375 15.1.7.2 Products offered 376 15.1.7.3 Recent developments 377 15.1.7.3.1 Deals 377 15.1.7.3.2 Expansions 377 15.1.7.3.3 Other developments 378 15.1.7.4 MnM view 378 15.1.7.4.1 Right to Win 378 15.1.7.4.2 Strategic choices 378 15.1.7.4.3 Weaknesses & competitive threats 379 15.1.8 VYGON 380 15.1.8.1 Business overview 380 15.1.8.2 Products offered 380 15.1.8.3 Recent developments 386 15.1.8.3.1 Deals 386 15.1.9 ANGIODYNAMICS 387 15.1.9.1 Business overview 387 15.1.9.2 Products offered 388 15.1.9.3 Recent developments 389 15.1.9.3.1 Product launches and approvals 389   15.1.10 MOZARC MEDICAL HOLDING LLC 390 15.1.10.1 Business overview 390 15.1.10.2 Products offered 390 15.1.10.3 Recent developments 391 15.1.10.3.1 Deals 391 15.1.10.3.2 Other developments 392 15.1.11 SPECTRUM VASCULAR 393 15.1.11.1 Business overview 393 15.1.11.2 Products offered 393 15.1.11.3 Recent developments 395 15.1.11.3.1 Deals 395 15.1.11.3.2 Expansions 396 15.1.12 AMECATH 397 15.1.12.1 Business overview 397 15.1.12.2 Products offered 397 15.1.13 MEDICAL COMPONENTS, INC. 400 15.1.13.1 Business overview 400 15.1.13.2 Products offered 400 15.1.13.3 Recent developments 402 15.1.13.3.1 Product launches and approvals 402 15.1.14 HEALTHLINE MEDICAL PRODUCTS 403 15.1.14.1 Business overview 403 15.1.14.2 Products offered 403 15.1.14.3 Recent developments 404 15.1.14.3.1 Deals 404 15.1.15 ACCESS VASCULAR, INC. 405 15.1.15.1 Business overview 405 15.1.15.2 Products offered 405 15.1.15.3 Recent developments 406 15.1.15.3.1 Product launches and approvals 406 15.1.15.3.2 Deals 406 15.1.15.3.3 Other developments 407 15.2 OTHER PLAYERS 408 15.2.1 ARGON MEDICAL DEVICES 408 15.2.2 PAKUMED MEDICAL PRODUCTS GMBH 409 15.2.3 GUANGDONG BAIHE MEDICAL TECHNOLOGY CO., LTD. 410 15.2.4 PFM MEDICAL GMBH 411 15.2.5 MEDI-TECH DEVICES PVT. LTD. 412 15.2.6 KIMAL 413 15.2.7 POLYMED 414 15.2.8 DELTA MED S.P.A. 415 15.2.9 NEWTECH MEDICAL DEVICES PVT. LTD. 416 15.2.10 SHANGHAI PUYI MEDICAL INSTRUMENTS CO., LTD. 417 16 RESEARCH METHODOLOGY 418 16.1 RESEARCH DATA 418 16.1.1 SECONDARY DATA 419 16.1.1.1 Key data from secondary sources 420 16.1.2 PRIMARY DATA 420 16.1.2.1 Key data from primary sources 422 16.1.2.2 Key industry insights 422 16.2 MARKET SIZE ESTIMATION 424 16.3 GROWTH FORECAST 428 16.4 MARKET BREAKDOWN & DATA TRIANGULATION 430 16.5 MARKET RANKING ANALYSIS 431 16.6 STUDY ASSUMPTIONS 431 16.7 RESEARCH LIMITATIONS 431 16.7.1 METHODOLOGY-RELATED LIMITATIONS 431 16.7.2 SCOPE-RELATED LIMITATIONS 432 16.8 RISK ASSESSMENT 432 17 APPENDIX 433 17.1 DISCUSSION GUIDE 433 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 441 17.3 CUSTOMIZATION OPTIONS 443 17.3.1 PRODUCT ANALYSIS 443 17.3.2 GEOGRAPHIC ANALYSIS 443 17.3.3 COMPANY INFORMATION 443 17.4 RELATED REPORTS 443 17.5 AUTHOR DETAILS 444
圖表清單 List of Tables & Figures
TABLE 1 VASCULAR ACCESS DEVICE MARKET: INCLUSIONS & EXCLUSIONS 40 TABLE 2 STANDARD CURRENCY CONVERSION RATES 41 TABLE 3 DIABETES POPULATION, BY REGION, 2024 VS. 2050 52 TABLE 4 TOP 10 COUNTRIES WITH THE HIGHEST SMOKING RATE (2025) 53 TABLE 5 GERIATRIC POPULATION, BY REGION (2015-2030) 54 TABLE 6 US: REIMBURSEMENT FOR VASCULAR PROCEDURES (2026) 55 TABLE 7 VASCULAR ACCESS DEVICE MARKET: PORTER’S FIVE FORCES ANALYSIS 65 TABLE 8 GDP CHANGE, BY KEY COUNTRY, 2021–2030 (IN USD BILLION) 68 TABLE 9 AVERAGE SELLING PRICE TREND OF CENTRAL VENOUS ACCESS DEVICES, BY TYPE (2023–2025) (USD) 76 TABLE 10 AVERAGE SELLING PRICE TREND OF PERIPHERAL VASCULAR ACCESS DEVICES, BY TYPE (2023−2025) (USD) 76 TABLE 11 AVERAGE SELLING PRICE TREND OF KEY PRODUCTS, BY APPLICATION (2023−2025) (USD) 77 TABLE 12 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY REGION (2023−2025) (USD) 78 TABLE 13 IMPORT DATA FOR HS CODE 9018.39, BY COUNTRY, 2021–2025 (USD THOUSANDS) 79 TABLE 14 EXPORT DATA FOR HS CODE 9018.39, BY COUNTRY, 2021–2025 (USD THOUSANDS) 79 TABLE 15 VASCULAR ACCESS DEVICE MARKET: MAJOR CONFERENCES & EVENTS IN 2026-2027E 80 TABLE 16 CASE STUDY 1: IMPROVING VASCULAR ACCESS OUTCOMES THROUGH STANDARDIZED VASCULAR ACCESS MANAGEMENT 83 TABLE 17 CASE STUDY 2: REDUCING CATHETER-RELATED BLOODSTREAM INFECTIONS USING ANTIMICROBIAL CENTRAL VENOUS CATHETERS 84 TABLE 18 CASE STUDY 3: IMPROVING VASCULAR ACCESS EFFICIENCY THROUGH ULTRASONOGRAPHY-GUIDED CATHETER PLACEMENT 84 TABLE 19 US ADJUSTED RECIPROCAL TARIFF RATES 85 TABLE 20 US: IMPACT OF TARIFFS 87 TABLE 21 ASIA PACIFIC: IMPACT OF TARIFFS 87 TABLE 22 EUROPE: IMPACT OF TARIFFS 88 TABLE 23 VASCULAR ACCESS DEVICE MARKET: MAJOR PATENTS 98 TABLE 24 BEST PRACTICES IN VASCULAR ACCESS DEVICE MARKET 102 TABLE 25 BEST PRACTICES IN CASE STUDIES OF AI IMPLEMENTATION IN THE VASCULAR ACCESS DEVICE MARKET 103 TABLE 26 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS 104 TABLE 27 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 109 TABLE 28 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 109 TABLE 29 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 110 TABLE 30 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 110 TABLE 31 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111 TABLE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VASCULAR ACCESS DEVICES 118 TABLE 33 KEY BUYING CRITERIA FOR VASCULAR ACCESS DEVICES, BY END USER 120 TABLE 34 VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024–2031 (USD MILLION) 125 TABLE 35 CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 126 TABLE 36 CENTRAL VENOUS ACCESS DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 126 TABLE 37 PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 127 TABLE 38 TUNNELED PRODUCT CATHETER BY KEY PLAYERS (2025) 129 TABLE 39 TUNNELED CATHETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 129 TABLE 40 TUNNELED CATHETERS MARKET VOLUME, BY REGION, 2024–2031 (UNITS) 130 TABLE 41 NON-TUNNELED PRODUCT CATHETER BY KEY PLAYERS (2025) 131 TABLE 42 NON-TUNNELED CATHETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 131 TABLE 43 NON-TUNNELED CATHETERS MARKET VOLUME, BY REGION, 2024–2031 (UNITS) 132 TABLE 44 IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 132 TABLE 45 IMPLANTABLE PORTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 133 TABLE 46 IMPLANTABLE CONVENTIONAL PORTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 134 TABLE 47 IMPLANTABLE POWER INJECTABLE PORTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 135 TABLE 48 PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 136 TABLE 49 PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 137 TABLE 50 PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 138 TABLE 51 PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 139 TABLE 52 PERIPHERAL INTRAVENOUS CATHETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 140 TABLE 53 PERIPHERAL INTRAVENOUS CATHETERS MARKET VOLUME, BY REGION, 2024–2031 (UNITS) 141 TABLE 54 MIDLINE CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 142 TABLE 55 MIDLINE CATHETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 142 TABLE 56 MIDLINE CATHETER-MAX BARRIER PRODUCT PORTFOLIO BY PRODUCT TYPE AND COMPANY (2025) 143 TABLE 57 MST MAX BARRIER MIDLINE CATHETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 144 TABLE 58 MIDLINE CATHETER -INTEGRATED/ACCELERATED PRODUCT PORTFOLIO BY PRODUCT TYPE AND COMPANY (2025) 145 TABLE 59 INTEGRATED/ACCELERATED MIDLINE CATHETERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 145 TABLE 60 BUTTERFLY/WINGED STEEL NEEDLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 147 TABLE 61 PERIPHERAL ARTERIAL CATHTER PRODUCT BY KEY PLAYERS (2025) 148 TABLE 62 PERIPHERAL ARTERIAL ACCESS DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 149 TABLE 63 PERIPHERAL ARTERIAL ACCESS DEVICES MARKET VOLUME, BY REGION, 2024–2031 (UNITS) 150 TABLE 64 VASCULAR ACCESS DEVICE ACCESSORIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 151 TABLE 65 INTRAOSSEOUS VASCULAR ACCESS DEVICE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 152 TABLE 66 VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024–2031 (USD MILLION) 155 TABLE 67 VASCULAR ACCESS DEVICE MARKET FOR INTRAVENOUS ROUTE, BY COUNTRY, 2024–2031 (USD MILLION) 156 TABLE 68 VASCULAR ACCESS DEVICE MARKET FOR SUBCUTANEOUS ROUTE, BY COUNTRY, 2024–2031 (USD MILLION) 157 TABLE 69 VASCULAR ACCESS DEVICE MARKET FOR INTRAOSSEOUS ROUTE, BY COUNTRY, 2024–2031 (USD MILLION) 158 TABLE 70 VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 161 TABLE 71 VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION) 162 TABLE 72 VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY COUNTRY, 2024–2031 (USD MILLION) 162 TABLE 73 VASCULAR ACCESS DEVICE MARKET FOR CHEMOTHERAPY, BY COUNTRY, 2024–2031 (USD MILLION) 163 TABLE 74 VASCULAR ACCESS DEVICE MARKET FOR OTHER DRUG ADMINISTRATION APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 164 TABLE 75 VASCULAR ACCESS DEVICE MARKET FOR FLUID & NUTRITION ADMINISTRATION, BY COUNTRY, 2024–2031 (USD MILLION) 166 TABLE 76 VASCULAR ACCESS DEVICE MARKET FOR BLOOD TRANSFUSION, BY COUNTRY, 2024–2031 (USD MILLION) 167 TABLE 77 VASCULAR ACCESS DEVICE MARKET FOR DIAGNOSTICS & TESTING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 168 TABLE 78 VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024–2031 (USD MILLION) 171 TABLE 79 VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 172 TABLE 80 VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY COUNTRY, 2024–2031 (USD MILLION) 172 TABLE 81 VASCULAR ACCESS DEVICE MARKET FOR PUBLIC HOSPITALS, BY COUNTRY, 2024–2031 (USD MILLION) 173 TABLE 82 VASCULAR ACCESS DEVICE MARKET FOR PRIVATE HOSPITALS, BY COUNTRY, 2024–2031 (USD MILLION) 174 TABLE 83 VASCULAR ACCESS DEVICE MARKET FOR CLINICS, BY COUNTRY, 2024–2031 (USD MILLION) 176 TABLE 84 VASCULAR ACCESS DEVICE MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 177 TABLE 85 VASCULAR ACCESS DEVICE MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 178 TABLE 86 VASCULAR ACCESS DEVICE MARKET, BY REGION, 2024–2031 (USD MILLION) 181 TABLE 87 NORTH AMERICA: VASCULAR ACCESS DEVICE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 182 TABLE 88 NORTH AMERICA: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024–2031 (USD MILLION) 183 TABLE 89 NORTH AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 183 TABLE 90 NORTH AMERICA VOLUME ANALYSIS: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (THOUSAND UNITS) 184 TABLE 91 NORTH AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 184 TABLE 92 NORTH AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 184 TABLE 93 NORTH AMERICA VOLUME ANALYSIS : PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (THOUSAND UNITS) 185 TABLE 94 NORTH AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 185 TABLE 95 NORTH AMERICA: MIDLINE CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 186 TABLE 96 NORTH AMERICA: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024–2031 (USD MILLION) 186 TABLE 97 NORTH AMERICA: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 186 TABLE 98 NORTH AMERICA: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION) 187 TABLE 99 NORTH AMERICA: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024–2031 (USD MILLION) 187 TABLE 100 NORTH AMERICA: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 187 TABLE 101 US: KEY MACROINDICATORS 188 TABLE 102 US: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024–2031 (USD MILLION) 189 TABLE 103 US: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 189 TABLE 104 US: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 189 TABLE 105 US: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 190 TABLE 106 US: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 190 TABLE 107 US: MIDLINE CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 190 TABLE 108 US: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024–2031 (USD MILLION) 191 TABLE 109 US: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 191 TABLE 110 US: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION) 191 TABLE 111 US: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024–2031 (USD MILLION) 192 TABLE 112 US: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 192 TABLE 113 CANADA: KEY MACROINDICATORS 193 TABLE 114 CANADA: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024–2031 (USD MILLION) 193 TABLE 115 CANADA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 193 TABLE 116 CANADA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 194 TABLE 117 CANADA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 194 TABLE 118 CANADA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 194 TABLE 119 CANADA: MIDLINE CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 195 TABLE 120 CANADA: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024–2031 (USD MILLION) 195 TABLE 121 CANADA: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 195 TABLE 122 CANADA: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION) 196 TABLE 123 CANADA: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024–2031 (USD MILLION) 196 TABLE 124 CANADA: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 196 TABLE 125 EUROPE: VASCULAR ACCESS DEVICE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 198 TABLE 126 EUROPE: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024–2031 (USD MILLION) 198 TABLE 127 EUROPE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 199 TABLE 128 EUROPE VOLUME ANALYSIS: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (THOUSAND UNITS) 199 TABLE 129 EUROPE: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 199 TABLE 130 EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 200 TABLE 131 EUROPE VOLUME ANALYSIS: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (THOUSAND UNITS) 200 TABLE 132 EUROPE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 201 TABLE 133 EUROPE: MIDLINE CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 201 TABLE 134 EUROPE: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024–2031 (USD MILLION) 201 TABLE 135 EUROPE: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 202 TABLE 136 EUROPE: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION) 202 TABLE 137 EUROPE: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024–2031 (USD MILLION) 202 TABLE 138 EUROPE: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 203 TABLE 139 GERMANY: KEY MACROINDICATORS 203 TABLE 140 GERMANY: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024–2031 (USD MILLION) 204 TABLE 141 GERMANY: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 204 TABLE 142 GERMANY: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 204 TABLE 143 GERMANY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 205 TABLE 144 GERMANY: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 205 TABLE 145 GERMANY: MIDLINE CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 205 TABLE 146 GERMANY: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024–2031 (USD MILLION) 206 TABLE 147 GERMANY: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 206 TABLE 148 GERMANY: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION) 206 TABLE 149 GERMANY: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024–2031 (USD MILLION) 207 TABLE 150 GERMANY: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 207 TABLE 151 UK: KEY MACROINDICATORS 208 TABLE 152 UK: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024–2031 (USD MILLION) 208 TABLE 153 UK: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 209 TABLE 154 UK: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 209 TABLE 155 UK: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 209 TABLE 156 UK: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 210 TABLE 157 UK: MIDLINE CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 210 TABLE 158 UK: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024–2031 (USD MILLION) 210 TABLE 159 UK: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 211 TABLE 160 UK: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION) 211 TABLE 161 UK: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024–2031 (USD MILLION) 211 TABLE 162 UK: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 212 TABLE 163 FRANCE: KEY MACROINDICATORS 212 TABLE 164 FRANCE: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024–2031 (USD MILLION) 213 TABLE 165 FRANCE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 213 TABLE 166 FRANCE: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 213 TABLE 167 FRANCE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 214 TABLE 168 FRANCE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 214 TABLE 169 FRANCE: MIDLINE CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 214 TABLE 170 FRANCE: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024–2031 (USD MILLION) 215 TABLE 171 FRANCE: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 215 TABLE 172 FRANCE: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION) 215 TABLE 173 FRANCE: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024–2031 (USD MILLION) 216 TABLE 174 FRANCE: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 216 TABLE 175 ITALY: KEY MACROINDICATORS 217 TABLE 176 ITALY: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024–2031 (USD MILLION) 217 TABLE 177 ITALY: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 217 TABLE 178 ITALY: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 218 TABLE 179 ITALY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 218 TABLE 180 ITALY: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 218 TABLE 181 ITALY: MIDLINE CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 219 TABLE 182 ITALY: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024–2031 (USD MILLION) 219 TABLE 183 ITALY: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 219 TABLE 184 ITALY: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION) 220 TABLE 185 ITALY: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024–2031 (USD MILLION) 220 TABLE 186 ITALY: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 220 TABLE 187 SPAIN: KEY MACROINDICATORS 221 TABLE 188 SPAIN: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024–2031 (USD MILLION) 221 TABLE 189 SPAIN: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 222 TABLE 190 SPAIN: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 222 TABLE 191 SPAIN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 222 TABLE 192 SPAIN: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 223 TABLE 193 SPAIN: MIDLINE CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 223 TABLE 194 SPAIN: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024–2031 (USD MILLION) 223 TABLE 195 SPAIN: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 224 TABLE 196 SPAIN: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION) 224 TABLE 197 SPAIN: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024–2031 (USD MILLION) 224 TABLE 198 SPAIN: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 225 TABLE 199 REST OF EUROPE: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024–2031 (USD MILLION) 226 TABLE 200 REST OF EUROPE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 226 TABLE 201 REST OF EUROPE: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 226 TABLE 202 REST OF EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 227 TABLE 203 REST OF EUROPE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 227 TABLE 204 REST OF EUROPE: MIDLINE CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 227 TABLE 205 REST OF EUROPE: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024–2031 (USD MILLION) 228 TABLE 206 REST OF EUROPE: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 228 TABLE 207 REST OF EUROPE: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION) 228 TABLE 208 REST OF EUROPE: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024–2031 (USD MILLION) 229 TABLE 209 REST OF EUROPE: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 229 TABLE 210 ASIA PACIFIC: VASCULAR ACCESS DEVICE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 231 TABLE 211 ASIA PACIFIC: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024–2031 (USD MILLION) 231 TABLE 212 ASIA PACIFIC: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 232 TABLE 213 ASIA PACIFIC: VOLUME ANLYSIS CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (THOUSAND UNITS) 232 TABLE 214 ASIA PACIFIC: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 232 TABLE 215 ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 233 TABLE 216 ASIA PACIFIC: VOLUME ANALYSIS PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (THOUSAND UNITS) 233 TABLE 217 ASIA PACIFIC: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 234 TABLE 218 ASIA PACIFIC: MIDLINE CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 234 TABLE 219 ASIA PACIFIC: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024–2031 (USD MILLION) 234 TABLE 220 ASIA PACIFIC: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 235 TABLE 221 ASIA PACIFIC: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION) 235 TABLE 222 ASIA PACIFIC: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024–2031 (USD MILLION) 235 TABLE 223 ASIA PACIFIC: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 236 TABLE 224 CHINA: KEY MACROINDICATORS 237 TABLE 225 CHINA: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024–2031 (USD MILLION) 237 TABLE 226 CHINA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 237 TABLE 227 CHINA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 238 TABLE 228 CHINA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 238 TABLE 229 CHINA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 238 TABLE 230 CHINA: MIDLINE CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 239 TABLE 231 CHINA: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024–2031 (USD MILLION) 239 TABLE 232 CHINA: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 239 TABLE 233 CHINA: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION) 240 TABLE 234 CHINA: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024–2031 (USD MILLION) 240 TABLE 235 CHINA: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 240 TABLE 236 INDIA: KEY MACROINDICATORS 241 TABLE 237 INDIA: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024–2031 (USD MILLION) 242 TABLE 238 INDIA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 242 TABLE 239 INDIA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 242 TABLE 240 INDIA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 243 TABLE 241 INDIA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 243 TABLE 242 INDIA: MIDLINE CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 243 TABLE 243 INDIA: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024–2031 (USD MILLION) 244 TABLE 244 INDIA: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 244 TABLE 245 INDIA: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION) 244 TABLE 246 INDIA: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024–2031 (USD MILLION) 245 TABLE 247 INDIA: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 245 TABLE 248 JAPAN: KEY MACROINDICATORS 246 TABLE 249 JAPAN: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024–2031 (USD MILLION) 246 TABLE 250 JAPAN: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 247 TABLE 251 JAPAN: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 247 TABLE 252 JAPAN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 247 TABLE 253 JAPAN: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 248 TABLE 254 JAPAN: MIDLINE CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 248 TABLE 255 JAPAN: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024–2031 (USD MILLION) 248 TABLE 256 JAPAN: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 249 TABLE 257 JAPAN: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION) 249 TABLE 258 JAPAN: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024–2031 (USD MILLION) 249 TABLE 259 JAPAN: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 250 TABLE 260 AUSTRALIA: KEY MACROINDICATORS 250 TABLE 261 AUSTRALIA: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024–2031 (USD MILLION) 251 TABLE 262 AUSTRALIA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 251 TABLE 263 AUSTRALIA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 251 TABLE 264 AUSTRALIA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 252 TABLE 265 AUSTRALIA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 252 TABLE 266 AUSTRALIA: MIDLINE CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 252 TABLE 267 AUSTRALIA: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024–2031 (USD MILLION) 253 TABLE 268 AUSTRALIA: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 253 TABLE 269 AUSTRALIA: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION) 253 TABLE 270 AUSTRALIA: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024–2031 (USD MILLION) 254 TABLE 271 AUSTRALIA: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 254 TABLE 272 SOUTH KOREA: KEY MACROINDICATORS 255 TABLE 273 SOUTH KOREA: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024–2031 (USD MILLION) 255 TABLE 274 SOUTH KOREA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 256 TABLE 275 SOUTH KOREA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 256 TABLE 276 SOUTH KOREA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 256 TABLE 277 SOUTH KOREA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 257 TABLE 278 SOUTH KOREA: MIDLINE CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 257 TABLE 279 SOUTH KOREA: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024–2031 (USD MILLION) 257 TABLE 280 SOUTH KOREA: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 258 TABLE 281 SOUTH KOREA: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION) 258 TABLE 282 SOUTH KOREA: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024–2031 (USD MILLION) 258 TABLE 283 SOUTH KOREA: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 259 TABLE 284 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024–2031 (USD MILLION) 259 TABLE 285 REST OF ASIA PACIFIC: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 260 TABLE 286 REST OF ASIA PACIFIC: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 260 TABLE 287 REST OF ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 260 TABLE 288 REST OF ASIA PACIFIC: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 261 TABLE 289 REST OF ASIA PACIFIC: MIDLINE CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 261 TABLE 290 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024–2031 (USD MILLION) 261 TABLE 291 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 262 TABLE 292 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION) 262 TABLE 293 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024–2031 (USD MILLION) 262 TABLE 294 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 263 TABLE 295 LATIN AMERICA: VASCULAR ACCESS DEVICE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 264 TABLE 296 LATIN AMERICA: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024–2031 (USD MILLION) 264 TABLE 297 LATIN AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 265 TABLE 298 LATIN AMERICA:VOLUME ANALYSIS BY CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (THOUSAND UNITS) 265 TABLE 299 LATIN AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 265 TABLE 300 LATIN AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 266 TABLE 301 LATIN AMERICA: VOLUME ANALYSIS BY PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (THOUSAND UNITS) 266 TABLE 302 LATIN AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 267 TABLE 303 LATIN AMERICA: MIDLINE CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 267 TABLE 304 LATIN AMERICA: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024–2031 (USD MILLION) 267 TABLE 305 LATIN AMERICA: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 268 TABLE 306 LATIN AMERICA: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION) 268 TABLE 307 LATIN AMERICA: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024–2031 (USD MILLION) 268 TABLE 308 LATIN AMERICA: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 269 TABLE 309 BRAZIL: KEY MACROINDICATORS 270 TABLE 310 BRAZIL: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024–2031 (USD MILLION) 270 TABLE 311 BRAZIL: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 270 TABLE 312 BRAZIL: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 271 TABLE 313 BRAZIL: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 271 TABLE 314 BRAZIL: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 271 TABLE 315 BRAZIL: MIDLINE CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 272 TABLE 316 BRAZIL: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024–2031 (USD MILLION) 272 TABLE 317 BRAZIL: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 272 TABLE 318 BRAZIL: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION) 273 TABLE 319 BRAZIL: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024–2031 (USD MILLION) 273 TABLE 320 BRAZIL: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 273 TABLE 321 MEXICO: KEY MACROINDICATORS 274 TABLE 322 MEXICO: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024–2031 (USD MILLION) 275 TABLE 323 MEXICO: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 275 TABLE 324 MEXICO: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 275 TABLE 325 MEXICO: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 276 TABLE 326 MEXICO: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 276 TABLE 327 MEXICO: MIDLINE CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 276 TABLE 328 MEXICO: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024–2031 (USD MILLION) 277 TABLE 329 MEXICO: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 277 TABLE 330 MEXICO: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION) 277 TABLE 331 MEXICO: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024–2031 (USD MILLION) 278 TABLE 332 MEXICO: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 278 TABLE 333 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024–2031 (USD MILLION) 279 TABLE 334 REST OF LATIN AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 279 TABLE 335 REST OF LATIN AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 280 TABLE 336 REST OF LATIN AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 280 TABLE 337 REST OF LATIN AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 280 TABLE 338 REST OF LATIN AMERICA: MIDLINE CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 281 TABLE 339 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024–2031 (USD MILLION) 281 TABLE 340 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 281 TABLE 341 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION) 282 TABLE 342 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024–2031 (USD MILLION) 282 TABLE 343 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 282 TABLE 344 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICE MARKET, BY REGION, 2024–2031 (USD MILLION) 283 TABLE 345 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024–2031 (USD MILLION) 284 TABLE 346 MIDDLE EAST & AFRICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 284 TABLE 347 MIDDLE EAST & AFRICA: VOLUME ANALYSIS CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (THOUSAND UNITS) 285 TABLE 348 MIDDLE EAST & AFRICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 285 TABLE 349 MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 285 TABLE 350 MIDDLE EAST & AFRICA: VOLUME ANALYSIS, BY PERIPHERAL VASCULAR ACCESS DEVICE TYPE, 2024–2031 (THOUSAND UNITS) 286 TABLE 351 MIDDLE EAST & AFRICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 286 TABLE 352 MIDDLE EAST & AFRICA: MIDLINE CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 287 TABLE 353 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024–2031 (USD MILLION) 287 TABLE 354 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 287 TABLE 355 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION) 288 TABLE 356 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024–2031 (USD MILLION) 288 TABLE 357 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 288 TABLE 358 GCC COUNTRIES: VASCULAR ACCESS DEVICE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 289 TABLE 359 GCC COUNTRIES: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024–2031 (USD MILLION) 290 TABLE 360 GCC COUNTRIES: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 290 TABLE 361 GCC COUNTRIES: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 290 TABLE 362 GCC COUNTRIES: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 291 TABLE 363 GCC COUNTRIES: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 291 TABLE 364 GCC COUNTRIES: MIDLINE CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 291 TABLE 365 GCC COUNTRIES: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024–2031 (USD MILLION) 292 TABLE 366 GCC COUNTRIES: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 292 TABLE 367 GCC COUNTRIES: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION) 292 TABLE 368 GCC COUNTRIES: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024–2031 (USD MILLION) 293 TABLE 369 GCC COUNTRIES: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 293 TABLE 370 KINGDOM OF SAUDI ARABIA: KEY MACROINDICATORS 294 TABLE 371 KINGDOM OF SAUDI ARABIA: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024–2031 (USD MILLION) 294 TABLE 372 KINGDOM OF SAUDI ARABIA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 294 TABLE 373 KINGDOM OF SAUDI ARABIA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 295 TABLE 374 KINGDOM OF SAUDI ARABIA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 295 TABLE 375 KINGDOM OF SAUDI ARABIA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 295 TABLE 376 KINGDOM OF SAUDI ARABIA: MIDLINE CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 296 TABLE 377 KINGDOM OF SAUDI ARABIA: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024–2031 (USD MILLION) 296 TABLE 378 KINGDOM OF SAUDI ARABIA: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 296 TABLE 379 KINGDOM OF SAUDI ARABIA: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION) 297 TABLE 380 KINGDOM OF SAUDI ARABIA: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024–2031 (USD MILLION) 297 TABLE 381 KINGDOM OF SAUDI ARABIA: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 297 TABLE 382 UNITED ARAB EMIRATES: KEY MACROINDICATORS 298 TABLE 383 UNITED ARAB EMIRATES: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024–2031 (USD MILLION) 298 TABLE 384 UNITED ARAB EMIRATES: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 299 TABLE 385 UNITED ARAB EMIRATES: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 299 TABLE 386 UNITED ARAB EMIRATES: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 299 TABLE 387 UNITED ARAB EMIRATES: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 300 TABLE 388 UNITED ARAB EMIRATES: MIDLINE CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 300 TABLE 389 UNITED ARAB EMIRATES: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024–2031 (USD MILLION) 300 TABLE 390 UNITED ARAB EMIRATES: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 301 TABLE 391 UNITED ARAB EMIRATES: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION) 301 TABLE 392 UNITED ARAB EMIRATES: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024–2031 (USD MILLION) 301 TABLE 393 UNITED ARAB EMIRATES: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 302 TABLE 394 REST OF GCC COUNTRIES: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024–2031 (USD MILLION) 302 TABLE 395 REST OF GCC COUNTRIES: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 303 TABLE 396 REST OF GCC COUNTRIES: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 303 TABLE 397 REST OF GCC COUNTRIES: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 303 TABLE 398 REST OF GCC COUNTRIES: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 304 TABLE 399 REST OF GCC COUNTRIES: MIDLINE CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 304 TABLE 400 REST OF GCC COUNTRIES: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024–2031 (USD MILLION) 304 TABLE 401 REST OF GCC COUNTRIES: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 305 TABLE 402 REST OF GCC COUNTRIES: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION) 305 TABLE 403 REST OF GCC COUNTRIES: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024–2031 (USD MILLION) 305 TABLE 404 REST OF GCC COUNTRIES: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 306 TABLE 405 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024–2031 (USD MILLION) 306 TABLE 406 REST OF MIDDLE EAST & AFRICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 307 TABLE 407 REST OF MIDDLE EAST & AFRICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 307 TABLE 408 REST OF MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 307 TABLE 409 REST OF MIDDLE EAST & AFRICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 308 TABLE 410 REST OF MIDDLE EAST & AFRICA: MIDLINE CATHETERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 308 TABLE 411 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024–2031 (USD MILLION) 308 TABLE 412 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 309 TABLE 413 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2031 (USD MILLION) 309 TABLE 414 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024–2031 (USD MILLION) 309 TABLE 415 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024–2031 (USD MILLION) 310 TABLE 416 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN VASCULAR ACCESS DEVICE, JANUARY 2023–MAY 2026 312 TABLE 417 VASCULAR ACCESS DEVICE MARKET: DEGREE OF COMPETITION 315 TABLE 418 US VASCULAR ACCESS DEVICE MARKET: DEGREE OF COMPETITION 317 TABLE 419 EUROPE VASCULAR ACCESS DEVICE MARKET: DEGREE OF COMPETITION 318 TABLE 420 VASCULAR ACCESS DEVICE MARKET: TYPE FOOTPRINT 322 TABLE 421 VASCULAR ACCESS DEVICE MARKET: ROUTE OF INSERTION FOOTPRINT 322 TABLE 422 VASCULAR ACCESS DEVICE MARKET: APPLICATION FOOTPRINT 323 TABLE 423 VASCULAR ACCESS DEVICE MARKET: REGION FOOTPRINT 324 TABLE 424 VASCULAR ACCESS DEVICE MARKET: DETAILED LIST OF KEY STARTUPS/SMES 327 TABLE 425 VASCULAR ACCESS DEVICE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUP/SME PLAYERS 328 TABLE 426 VASCULAR ACCESS DEVICE MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 331 TABLE 427 VASCULAR ACCESS DEVICE MARKET: DEALS, JANUARY 2023–MAY 2026 332 TABLE 428 VASCULAR ACCESS DEVICE MARKET: EXPANSIONS, JANUARY 2023–MAY 2026 333 TABLE 429 VASCULAR ACCESS DEVICE MARKET: OTHER DEVELOPMENTS, JANUARY 2023–MAY 2026 335 TABLE 430 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 336 TABLE 431 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED 337 TABLE 432 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES, JANUARY 2023–MAY 2026 343 TABLE 433 BECTON, DICKINSON AND COMPANY: OTHER DEVELOPMENTS, JANUARY 2023–MAY 2026 343 TABLE 434 TERUMO CORPORATION: COMPANY OVERVIEW 345 TABLE 435 TERUMO CORPORATION: PRODUCTS OFFERED 346 TABLE 436 TERUMO CORPORATION: PRODUCT LAUNCHES, JANUARY 2023–MAY 2026 347 TABLE 437 TERUMO CORPORATION: EXPANSIONS, JANUARY 2023–MAY 2026 348 TABLE 438 TERUMO CORPORATION: OTHER DEVELOPMENTS, JANUARY 2023–MAY 2026 348 TABLE 439 TELEFLEX INCORPORATED: COMPANY OVERVIEW 349 TABLE 440 TELEFLEX INCORPORATED: PRODUCTS OFFERED 350 TABLE 441 TELEFLEX INCORPORATED: PRODUCT LAUNCHES, JANUARY 2023–MAY 2026 352 TABLE 442 TELEFLEX INCORPORATED: DEALS, JANUARY 2023–MAY 2026 353 TABLE 443 TELEFLEX INCORPORATED: OTHER DEVELOPMENTS, JANUARY 2023–MAY 2026 353 TABLE 444 ICU MEDICAL, INC.: COMPANY OVERVIEW 355 TABLE 445 ICU MEDICAL, INC.: PRODUCTS OFFERED 356 TABLE 446 ICU MEDICAL, INC.: PRODUCT LAUNCHES, JANUARY 2023–MAY 2026 359 TABLE 447 ICU MEDICAL, INC.: EXPANSIONS, JANUARY 2023–MAY 2026 360 TABLE 448 ICU MEDICAL, INC.: OTHER DEVELOPMENTS, JANUARY 2023–MAY 2026 360 TABLE 449 B. BRAUN SE: COMPANY OVERVIEW 362 TABLE 450 B. BRAUN SE: PRODUCTS OFFERED 363 TABLE 451 B. BRAUN SE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 368 TABLE 452 B. BRAUN SE: OTHER DEVELOPMENTS, JANUARY 2023–MAY 2026 369 TABLE 453 MERIT MEDICAL SYSTEMS: COMPANY OVERVIEW 370 TABLE 454 MERIT MEDICAL SYSTEMS: PRODUCTS OFFERED 371 TABLE 455 MERIT MEDICAL SYSTEMS: PRODUCT LAUNCHES, JANUARY 2023–MAY 2026 373 TABLE 456 MERIT MEDICAL SYSTEMS: DEALS, JANUARY 2023–MAY 2026 374 TABLE 457 MERIT MEDICAL SYSTEMS: OTHER DEVELOPMENTS, JANUARY 2023–MAY 2026 374 TABLE 458 NIPRO: COMPANY OVERVIEW 375 TABLE 459 NIPRO CORPORATION: PRODUCTS OFFERED 376 TABLE 460 NIPRO CORPORATION: DEALS, JANUARY 2023–MAY 2026 377 TABLE 461 NIPRO CORPORATION: EXPANSIONS, JANUARY 2023–MAY 2026 377 TABLE 462 NIPRO CORPORATION: OTHER DEVELOPMENTS, JANUARY 2023–MAY 2026 378 TABLE 463 VYGON: COMPANY OVERVIEW 380 TABLE 464 VYGON: PRODUCTS OFFERED 380 TABLE 465 VYGON: DEALS, JANUARY 2023–MAY 2026 386 TABLE 466 ANGIODYNAMICS: COMPANY OVERVIEW 387 TABLE 467 ANGIODYNAMICS: PRODUCTS OFFERED 388 TABLE 468 ANGIODYNAMICS: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2023–MAY 2026 389 TABLE 469 MOZARC MEDICAL HOLDING LLC: COMPANY OVERVIEW 390 TABLE 470 MOZARC MEDICAL HOLDING LLC: PRODUCTS OFFERED 390 TABLE 471 MOZARC MEDICAL HOLDING LLC: DEALS, JANUARY 2023–MAY 2026 391 TABLE 472 MOZARC MEDICAL HOLDING LLC: OTHER DEVELOPMENTS, JANUARY 2023–MAY 2026 392 TABLE 473 SPECTRUM VASCULAR: COMPANY OVERVIEW 393 TABLE 474 SPECTRUM VASCULAR: PRODUCTS OFFERED 393 TABLE 475 SPECTRUM VASCULAR: DEALS, JANUARY 2023–MAY 2026 395 TABLE 476 SPECTRUM VASCULAR: EXPANSIONS, JANUARY 2023–MAY 2026 396 TABLE 477 AMECATH: COMPANY OVERVIEW 397 TABLE 478 AMECATH: PRODUCTS OFFERED 397 TABLE 479 MEDICAL COMPONENTS, INC.: COMPANY OVERVIEW 400 TABLE 480 MEDICAL COMPONENTS, INC.: PRODUCTS OFFERED 400 TABLE 481 MEDICAL COMPONENTS, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2023–MAY 2026 402 TABLE 482 HEALTHLINE MEDICAL PRODUCTS: COMPANY OVERVIEW 403 TABLE 483 HEALTHLINE MEDICAL PRODUCTS: PRODUCTS OFFERED 403 TABLE 484 HEALTHLINE MEDICAL PRODUCTS: DEALS, JANUARY 2023–MAY 2026 404 TABLE 485 ACCESS VASCULAR, INC.: COMPANY OVERVIEW 405 TABLE 486 ACCESS VASCULAR, INC.: PRODUCTS OFFERED 405 TABLE 487 ACCESS VASCULAR, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2023–MAY 2026 406 TABLE 488 ACCESS VASCULAR, INC.: DEALS, JANUARY 2023–MAY 2026 406 TABLE 489 ACCESS VASCULAR, INC.: OTHER DEVELOPMENTS, JANUARY 2023–MAY 2026 407 TABLE 490 ARGON MEDICAL DEVICES: COMPANY OVERVIEW 408 TABLE 491 PAKUMED MEDICAL PRODUCTS GMBH: COMPANY OVERVIEW 409 TABLE 492 GUANGDONG BAIHE MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 410 TABLE 493 PFM MEDICAL GMBH: COMPANY OVERVIEW 411 TABLE 494 MEDI-TECH DEVICES PVT. LTD.: COMPANY OVERVIEW 412 TABLE 495 KIMAL: COMPANY OVERVIEW 413 TABLE 496 POLYMED: COMPANY OVERVIEW 414 TABLE 497 DELTA MED S.P.A.: COMPANY OVERVIEW 415 TABLE 498 NEWTECH MEDICAL DEVICES PVT. LTD.: COMPANY OVERVIEW 416 TABLE 499 SHANGHAI PUYI MEDICAL INSTRUMENTS CO., LTD.: COMPANY OVERVIEW 417 TABLE 500 VASCULAR STENTS MARKET: STUDY ASSUMPTIONS 431 TABLE 501 VASCULAR STENTS MARKET: RISK ASSESSMENT ANALYSIS 432 FIGURE 1 VASCULAR ACCESS DEVICE MARKET: MARKETS COVERED & REGIONS CONSIDERED 39 FIGURE 2 MARKET SCENARIO 43 FIGURE 3 GLOBAL VASCULAR ACCESS DEVICE MARKET, 2024–2031 44 FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN VASCULAR ACCESS DEVICE MARKET, 2024–2026 44 FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF VASCULAR ACCESS DEVICE MARKET 45 FIGURE 6 HIGH-GROWTH SEGMENTS IN VASCULAR ACCESS DEVICE MARKET, 2026–2031 46 FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN VASCULAR ACCESS DEVICE MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 47 FIGURE 8 RISING INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET GROWTH 48 FIGURE 9 HOSPITALS AND AMBULATORY CARE CENTERS ACCOUNT FOR LARGEST MARKET SHARE IN ASIA PACIFIC, 2025 49 FIGURE 10 CHINA TO GROW AT HIGHEST CAGR TILL 2026-2031 50 FIGURE 11 VASCULAR ACCESS DEVICE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 51 FIGURE 12 NEW CANCER CASES: BY COUNTRY, 2025 (MILLION) 55 FIGURE 13 VASCULAR ACCESS DEVICE MARKET: PORTER'S FIVE FORCES ANALYSIS 66 FIGURE 14 VASCULAR ACCESS DEVICE MARKET: SUPPLY CHAIN ANALYSIS 72 FIGURE 15 VASCULAR ACCESS DEVICE MARKET: VALUE CHAIN ANALYSIS 74 FIGURE 16 VASCULAR ACCESS DEVICE MARKET: ECOSYSTEM ANALYSIS 75 FIGURE 17 VASCULAR ACCESS DEVICE MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 82 FIGURE 18 VASCULAR ACCESS DEVICE MARKET: INVESTMENT & FUNDING SCENARIO (2023–2026) 83 FIGURE 19 PERIPHERAL VENOUS ACCESS DEVICES: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2016–MAY 2026) 96 FIGURE 20 TOP APPLICANT COUNTRIES/REGIONS FOR VASCULAR ACCESS DEVICE PATENTS (JANUARY 2023–MAY 2026) 97 FIGURE 21 KEY FEATURES OF AI/GENERATIVE AI IN VASCULAR ACCESS DEVICE MARKET 102 FIGURE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VASCULAR ACCESS DEVICES 118 FIGURE 23 KEY BUYING CRITERIA FOR VASCULAR ACCESS DEVICES, BY END USER 120 FIGURE 24 NORTH AMERICA: VASCULAR ACCESS DEVICE MARKET SNAPSHOT 182 FIGURE 25 ASIA PACIFIC: VASCULAR ACCESS DEVICE MARKET SNAPSHOT 230 FIGURE 26 REVENUE ANALYSIS OF KEY PLAYERS IN VASCULAR ACCESS MARKET, 2023–2025 314 FIGURE 27 GLOBAL: MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025 315 FIGURE 28 US: MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025 317 FIGURE 29 EUROPE: MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025 318 FIGURE 30 VASCULAR ACCESS DEVICE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 320 FIGURE 31 VASCULAR ACCESS DEVICE MARKET: COMPANY FOOTPRINT 321 FIGURE 32 VASCULAR ACCESS DEVICE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 326 FIGURE 33 EV/EBITDA OF KEY VENDORS FOR VASCULAR ACCESS DEVICE 329 FIGURE 34 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS FOR VASCULAR ACCESS DEVICES 329 FIGURE 35 VASCULAR ACCESS DEVICE MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 330 FIGURE 36 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2025) 337 FIGURE 37 TERUMO CORPORATION: COMPANY SNAPSHOT (2025) 346 FIGURE 38 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2025) 350 FIGURE 39 ICU MEDICAL, INC.: COMPANY SNAPSHOT (2025) 356 FIGURE 40 B. BRAUN SE: COMPANY SNAPSHOT (2025) 363 FIGURE 41 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2025) 371 FIGURE 42 NIPRO CORPORATION: COMPANY SNAPSHOT (2025) 376 FIGURE 43 ANGIODYNAMICS: COMPANY SNAPSHOT (2025) 388 FIGURE 44 RESEARCH DESIGN 418 FIGURE 45 PRIMARY SOURCES 421 FIGURE 46 PRIMARY BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 423 FIGURE 47 BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS 423 FIGURE 48 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 424 FIGURE 49 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 425 FIGURE 50 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2025) 425 FIGURE 51 SUPPLY-SIDE ANALYSIS: VASCULAR ACCESS DEVICE MARKET 426 FIGURE 52 TOP-DOWN APPROACH 426 FIGURE 53 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF VASCULAR ACCESS DEVICES MARKET (2026–2031) 428 FIGURE 54 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS OF VASCULAR ACCESS DEVICE MARKET (2025) 429 FIGURE 55 DATA TRIANGULATION METHODOLOGY 430

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們